Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19312-14-2

Post Buying Request

19312-14-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19312-14-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 19312-14-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,3,1 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 19312-14:
(7*1)+(6*9)+(5*3)+(4*1)+(3*2)+(2*1)+(1*4)=92
92 % 10 = 2
So 19312-14-2 is a valid CAS Registry Number.

19312-14-2Relevant articles and documents

Synthesis and pharmacological screening of some novel chalconyl derivatives of substituted phenyl semicarbazide

Singh, Hemendra Pratap,Pandeya,Chauhan,Sharma, Chandra Shekhar

experimental part, p. 74 - 80 (2012/02/04)

In the present study, we have synthesized chalcone and semicarbazide-linked chalonyl derivatives and the titled compounds confirmed by MS, IR, and 1H NMR techniques. The anticonvulsant activity was determined by maximal electroshock (MES) induced seizure method. A majority of the compounds exhibited significant anticonvulsant activity after intraperitoneal administration. The results show the importance of hydrogen bonding for activity. In the present study 5e, 5h, 5i, 6e, 6h, and 6i emerged as the most active molecules, showed significant anticonvulsant of activity. Springer Science+Business Media, LLC 2010.

Chalconsemicarbazone: A new scaffold for antiepileptic drug discovery

Singh, Hemendra Pratap,Chauhan,Pandeya,Sharma, Chandra Shekhar

experimental part, p. 103 - 106 (2010/08/06)

During our investigation in the area of epileptic drug discovery, we have identified that the available conventional antiepileptic drugs are effective in 60-80% patients and in specific type of seizures and having various undesirable side effects. But in present time a new class aryl semicarbazone is emerged as new pharmacophore in epileptic drug discovery having broad spectrum activity. On the bases of work done in this area we have applied hybridization of pharmacophore strategy of drug design and developed a new pharmacophore. We have also designed a scheme for synthesizing such pharmacophore and performed their pharmacological screening for the protection of seizures, behavioral study and CNS activity. The compound 1-[1-(2,4-dihydroxyphenyl)-3-(2-hydroxyphenyl) allylidene]-4-(2-fluorophenyl) semicarbazide (8) emerged as the most active prototype molecule in all the models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19312-14-2